Health
Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects – News-Medical.Net
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme.
The study results, published today in Nature Metabolism, provide proof…
-
Business13 hours agoWarning! These ASX 200 shares were just downgraded
-
Business11 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News6 hours agoVegetables and herbs you can easily and cheaply grow from seeds
-
General22 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts